PEGLyte bowel preparation
Phase 1Small molecule
PEGLyte bowel preparation is one of 9 small molecule programs targeting Bowel Preparation. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
15 competitors in Bowel Preparation
#DrugCompanyPhaseTrials
1Resotran
TakedaPhase 3
Dulcolax
Boehringer IngelheimPhase 3
Mechanical Bowel Preparation
HHelsinki University Central Hospital
Phase 3
Reglan
IIstituto Clinico Humanitas
Preclinical
Senna
MMedtronic - MITG
Preclinical
PEGLyte bowel preparation
CCentre hospitalier de l'Université de Montréal (CHUM)
Phase 1
Plenvu
JJohannes Gutenberg University Mainz
Preclinical
PEG-ELS
FerringPreclinical
CLENPIQ
FerringPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Bowel Preparation1 trial
Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery
Recruiting·—·Phase 1·NCT06831539·20 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for PEGLyte bowel preparation. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details